- Health Sciences Building, 155 College Street, Room 108
- Bioethics Seminars
- December 7, 2016 from 4:10pm to 5:30pm
Speakers: Zahava Rosenberg-Yunger, Hon.BSc, MA, PhD, Director, Health Policy and Research, Ontario Pharmacists Association; Lee Verweel, BSc, MSc, Research Coordinator, Ontario Pharmacists Association
In 2001, the Canadian government legalized medical marijuana (MMJ). MMJ regulations were revised in 2013 restricting its sale and distribution by shifting to licensed suppliers rather than personally grown supplies in an effort to increase both healthcare providers’ involvement and industry regulation. Recently, Health Canada announced the new Access to Cannabis for Medical Purposes Regulations, which has made additional amendments to the 2013 regulations. This has stimulated much debate by government, MMJ advocates, and stakeholders in healthcare, surrounding MMJ including ethical issues pertaining to patient access and safety.
The Ontario Pharmacists Association is the largest advocacy organization, continuing education, and drug information provider for pharmacy professionals in Canada. We are dedicated to working on behalf of patients and pharmacy professionals across the province to evolve the practice of pharmacy and advocate for the highest standards of professional excellence. The Ontario Pharmacists Association, along with our colleagues at the Canadian Pharmacists Association, believe that pharmacies are capable of distributing and monitoring medical marijuana under any revised legislation that may come about as a result of the legalization and decriminalization of marijuana in Canada. The objective of this talk is to highlight the role of pharmacy in addressing some of the ethical challenges raised by MMJ including patient safety, access and education.
Open to the public.